0000919574-18-008210.txt : 20181228 0000919574-18-008210.hdr.sgml : 20181228 20181228173023 ACCESSION NUMBER: 0000919574-18-008210 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181226 FILED AS OF DATE: 20181228 DATE AS OF CHANGE: 20181228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CDK ASSOCIATES, L.L.C. CENTRAL INDEX KEY: 0001576081 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 181258130 BUSINESS ADDRESS: STREET 1: C/O CAXTON CORPORATION STREET 2: 731 ALEXANDER ROAD, BUILDING #2 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-419-1800 MAIL ADDRESS: STREET 1: C/O CAXTON CORPORATION STREET 2: 731 ALEXANDER ROAD, BUILDING #2 CITY: PRINCETON STATE: NJ ZIP: 08540 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morenstein Scott D CENTRAL INDEX KEY: 0001576113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 181258131 MAIL ADDRESS: STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAXTON CORP CENTRAL INDEX KEY: 0001388551 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 181258132 BUSINESS ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-419-1800 MAIL ADDRESS: STREET 1: 731 ALEXANDER ROAD STREET 2: BUILDING 2, SUITE 500 CITY: PRINCETON STATE: NJ ZIP: 08540 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kovner Bruce CENTRAL INDEX KEY: 0001325713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 181258133 MAIL ADDRESS: STREET 1: C/O CAXTON ASSOCIATES STREET 2: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 ownership.xml X0306 4 2018-12-26 0 0001183765 Molecular Templates, Inc. MTEM 0001576081 CDK ASSOCIATES, L.L.C. C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BLDG. 2 PRINCETON NJ 08540 1 0 0 0 0001576113 Morenstein Scott D C/O CAXTON ALTERNATIVE MANAGEMENT LP 1330 SIXTH AVENUE, 20TH FLOOR NEW YORK NY 10019 1 0 0 0 0001388551 CAXTON CORP 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540 1 0 0 0 0001325713 Kovner Bruce C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BLDG. 2 PRINCETON NJ 08540 1 0 0 0 Common Stock 2018-12-26 4 P 0 25000 3.45 A 1584241 D These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. CDK Associates, L.L.C., By: Caxton Corporation, its Manager,By: /s/ Heath Weisberg, General Counsel 2018-12-28 /s/ Scott D. Morenstein 2018-12-28 Caxton Corporation, By: /s/ Heath Weisberg, General Counsel 2018-12-28 Bruce Kovner, By: /s/ Heath Weisberg, Attorney-in-Fact 2018-12-28